Volker Gerdts

researcher

Volker Gerdts is …
instance of (P31):
humanQ5

P734family nameGerdtsQ37077449
GerdtsQ37077449
GerdtsQ37077449
P735given nameVolkerQ1576766
VolkerQ1576766
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q94523185A Porcine Model of Zika Virus Infection to Profile the In Utero Interferon Alpha Response
Q42463233A comparison between isolated blood dendritic cells and monocyte-derived dendritic cells in pigs
Q91440678A lipidic delivery system of a triple vaccine adjuvant enhances mucosal immunity following nasal administration in mice
Q38915769A lumpy skin disease virus deficient of an IL-10 gene homologue provides protective immunity against virulent capripoxvirus challenge in sheep and goats
Q38672711A novel combination adjuvant platform for human and animal vaccines.
Q43722893A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity
Q38677197Adjuvants for veterinary vaccines--types and modes of action
Q40250122Administration of Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) and Avian Beta Defensin as Adjuvants in Inactivated Inclusion Body Hepatitis Virus and its Hexon Protein-Based Experimental Vaccine Formulations in Chickens
Q43739433Administration of poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) as adjuvant activated mixed Th1/Th2 immune responses in pigs
Q50578339All three classes of CpG ODNs up-regulate IP-10 gene in pigs.
Q40524902Analysis of immune responses to recombinant proteins from strains of Mycoplasma mycoides subsp. mycoides, the causative agent of contagious bovine pleuropneumonia
Q38067243Animal models for neonatal diseases in humans
Q36028001Antibody and Cytokine Responses of Koalas (Phascolarctos cinereus) Vaccinated with Recombinant Chlamydial Major Outer Membrane Protein (MOMP) with Two Different Adjuvants
Q34890075Antibody response specific to the capsular polysaccharide is impaired in Streptococcus suis serotype 2-infected animals
Q83151639Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations
Q37810793Biological roles of host defense peptides: lessons from transgenic animals and bioengineered tissues
Q38629725CD71+ erythroid suppressor cells impair adaptive immunity against Bordetella pertussis.
Q34290818Canadian Adjuvant Initiative Workshop, March 26-27, 2013--Ottawa, Canada
Q38090219Capripoxvirus-vectored vaccines against livestock diseases in Africa.
Q40586201Capsular polysaccharide from Mycoplasma mycoides subsp. mycoides shows potential for protection against contagious bovine pleuropneumonia
Q38065559Carrier molecules for use in veterinary vaccines
Q35826657Caspase-1 Dependent IL-1β Secretion and Antigen-Specific T-Cell Activation by the Novel Adjuvant, PCEP.
Q37821483Combination adjuvants: the next generation of adjuvants?
Q33291765Commensal bacteria and expression of two major intestinal chemokines, TECK/CCL25 and MEC/CCL28, and their receptors
Q44877345Contribution of the swine model in the study of human sexually transmitted infections
Q45324576Corrigendum to "Zika Virus Causes Persistent Infection in Porcine Conceptuses and May Impair Health in Offspring".
Q44929230CpG oligodeoxynucleotides activate innate immune response that suppresses infectious bronchitis virus replication in chicken embryos
Q42206659CpG-ODNs induced changes in cytokine/chemokines genes expression associated with suppression of infectious bronchitis virus replication in chicken lungs
Q84957757CpG-Recoding in Zika Virus Genome Causes Host-Age-Dependent Attenuation of Infection With Protection Against Lethal Heterologous Challenge in Mice
Q40569357DNA vaccination in utero: a new approach to induce protective immunity in the newborn
Q84208638Differential activation and maturation of two porcine DC populations following TLR ligand stimulation
Q44449501Does adjuvanticity depend on the ability to recruit specific immune cells?
Q37224019Early immune response following Salmonella enterica subspecies enterica serovar Typhimurium infection in porcine jejunal gut loops
Q37546452Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission.
Q40811628Experimental evaluation of inactivated and live attenuated vaccines against Mycoplasma mycoides subsp. mycoides
Q53767845Expression of TECK/CCL25 and MEC/CCL28 chemokines and their respective receptors CCR9 and CCR10 in porcine mucosal tissues.
Q51996236Expression of mucosal chemokines TECK/CCL25 and MEC/CCL28 during fetal development of the ovine mucosal immune system.
Q42245234Failure of a VapA/CpG oligodeoxynucleotide vaccine to protect foals against experimental Rhocococcus equi pneumonia despite induction of VapA-specific antibody and interferon-γ response
Q39594585Future vaccines for a globalized world
Q58615671High dosage of zinc modulates T-cells in a time-dependent manner within porcine gut-associated lymphatic tissue
Q37257486Humoral and cellular factors of maternal immunity in swine.
Q39021470Immune responses to in ovo vaccine formulations containing inactivated fowl adenovirus 8b with poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) and avian beta defensin as adjuvants in chickens
Q33757880Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance
Q44769788Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis
Q58556925In Ovo Administration of Innate Immune Stimulants and Protection from Early Chick Mortalities due to Yolk Sac Infection
Q48055540Induction, regulation and physiological role of IL-17 secreting helper T-cells isolated from PBMC, thymus, and lung lymphocytes of young pigs
Q40417195Infection with Bordetella parapertussis but not Bordetella pertussis causes pertussis-like disease in older pigs
Q46326832Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets
Q89514925Innate immunemodulator containing adjuvant formulated HA based vaccine protects mice from lethal infection of highly pathogenic avian influenza H5N1 virus
Q49898999Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and reduced lung viral titres in pigs
Q40185695Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in mice
Q38492768Large animal models for vaccine development and testing.
Q34601948Maternal immunity provides protection against pertussis in newborn piglets
Q42623410Molecular cloning and functional characterization of porcine CCL28: possible involvement in homing of IgA antibody secreting cells into the mammary gland.
Q38195758Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
Q36447720Mucosal delivery of vaccines in domestic animals
Q37833985Multistage vaccines containing outer membrane, type III secretion system and inclusion membrane proteins protects against a Chlamydia genital tract infection and pathology
Q42320290Neonatal pigs are susceptible to experimental Zika virus infection
Q45927257New insights into the dual recruitment of IgA+ B cells in the developing mammary gland.
Q42262598Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies
Q37872669Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate
Q35170057Oral antigen exposure in newborn piglets circumvents induction of oral tolerance in response to intraperitoneal vaccination in later life.
Q34116871PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens
Q43464015PCPP (poly[di(carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune responses in mice
Q43491506Pathotypic and molecular characterization of a fowl adenovirus associated with inclusion body hepatitis in Saskatchewan chickens
Q56381178Persistent Zika virus infection in porcine conceptuses is associated with elevated in utero cortisol levels
Q37534284Peste des petits ruminants virus tissue tropism and pathogenesis in sheep and goats following experimental infection
Q34716772Porcine neonatal blood dendritic cells, but not monocytes, are more responsive to TLRs stimulation than their adult counterparts
Q40650298Protection of neonates and infants by maternal immunization
Q40342590Protective Role of Passively Transferred Maternal Cytokines against Bordetella pertussis Infection in Newborn Piglets
Q43781942Protein chimeras containing the Mycoplasma bovis GAPDH protein and bovine host-defence peptides retain the properties of the individual components
Q40760184Recombinant Mycoplasma mycoides proteins elicit protective immune responses against contagious bovine pleuropneumonia
Q96434028Regional Dichotomy in Enteric Mucosal Immune Responses to a Persistent Mycobacterium avium ssp. paratuberculosis Infection
Q36758318S1 domain of the porcine epidemic diarrhea virus spike protein as a vaccine antigen
Q37834135Safety and immunogenicity of a prototype anti-Chlamydia pecorum recombinant protein vaccine in lambs and pregnant ewes.
Q83483082Stability of expression of reference genes in porcine peripheral blood mononuclear and dendritic cells
Q57198394Strategies to Stimulate Innate Immunity for Designing Effective Vaccine Adjuvants
Q38358558Strategies to link innate and adaptive immunity when designing vaccine adjuvants
Q78177266Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring.
Q89967837Susceptibility of Chicken Embryos, Sheep, Cattle, Pigs, and Chickens to Zika Virus Infection
Q92243227Synthetic Cationic Peptide IDR-1002 and Human Cathelicidin LL37 Modulate the Cell Innate Response but Differentially Impact PRRSV Replication in vitro
Q92151381The African strain of Zika virus causes more severe in utero infection than Asian strain in a porcine fetal transmission model
Q36962817The benefits of using diverse animal models for studying pertussis.
Q34492573The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets
Q37966290The pig: a model for human infectious diseases
Q37622995The potential of polyphosphazenes for delivery of vaccine antigens and immunotherapeutic agents
Q48003495Toll-like receptor 4 variants reduce airway response in human subjects at high endotoxin levels in a swine facility.
Q37015991Use of animal models in the development of human vaccines
Q55472927Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein.
Q37843628Vaccination of koalas (Phascolarctos cinereus) with a recombinant chlamydial major outer membrane protein adjuvanted with poly I:C, a host defense peptide and polyphosphazine, elicits strong and long lasting cellular and humoral immune responses.
Q35826767Vaccine Potentiation by Combination Adjuvants
Q38783240Vaccines for porcine epidemic diarrhea virus and other swine coronaviruses
Q37356542Veterinary vaccines: alternatives to antibiotics?
Q43046870Zika Virus Causes Persistent Infection in Porcine Conceptuses and may Impair Health in Offspring
Q95929052Zika Virus with Increased CpG Dinucleotide Frequencies Shows Oncolytic Activity in Glioblastoma Stem Cells
Q34343647c-di-GMP enhances protective innate immunity in a murine model of pertussis

Search more.